- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06148584
Testing a Barbershop-based HIV Prevention Initiative Among Men (TRIM)
Feasibility and Acceptability of a Barbershop Based HIV Prevention Initiative Among Heterosexual Men in Kalangala Islands, Uganda: A Cluster Randomized Trial
Study Overview
Status
Conditions
Intervention / Treatment
- Behavioral: General, status-neutral HIV education
- Diagnostic test: HIV self-test kits
- Other: Information about where to receive HIV prevention services
- Behavioral: Barber-led peer support group education
- Behavioral: Facility-based HIV risk reduction counseling
- Diagnostic test: Facility-based HIV testing
- Other: Information about facility distributed HIV self-test kits
- Diagnostic test: STI testing
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Caitlin Scoville, MPH
- Phone Number: 202-464-3750
- Email: cscoville@fhi360.org
Study Contact Backup
- Name: Michelle Robinson
- Phone Number: 919-321-3585
- Email: mrobinson@fhi360.org
Study Locations
-
-
-
Kampala, Uganda
- MU-JHU Research Collaboration (MUJHU CARE LTD) CRS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Persons who identify as a heterosexual male and meet all of the following criteria are eligible for inclusion in this study:
Age ≥ 16 years
a. Any participants 16-17 years old will be enrolled following the Uganda National Council for Science and Technology (UNCST) guidelines for mature and emancipated minors
- Able and willing to provide informed consent
Behaviorally vulnerable to HIV, based on self-report of at least one of the following in the last three months:
- Had condomless sex with a person of unknown HIV status or a person living with HIV
- Had more than one sexual partner
- HIV negative per Ugandan Ministry of Health guidelines and the Study-specific Procedures (SSP) Manual
- Is a regular customer at a participating barbershop as defined in the SSP Manual
Exclusion Criteria:
Persons who meet any of the following criteria will be excluded from this study:
- Not planning to stay in the study catchment area in the next 12 months
- Any other condition that in the opinion of the Investigator of Record (IoR)/designee, would preclude informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
Participants who report sex with other men will not be excluded from this study so long as they meet the inclusion and exclusion criteria listed above.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention Barbershops Group
Participants recruited from intervention barbershops will receive the barbershop-based HIV prevention initiative.
The trained barber will provide the following services during regular haircut services: general, status-neutral HIV education, HIV self-test kits, and information about where to receive HIV prevention services.
The barber will also lead peer support group education every two months for clients enrolled in the study.
|
General, status-neutral HIV education
HIV self-test kits
Information about where to receive HIV prevention services
Barber-led peer support group education
|
Active Comparator: Control Barbershops Group
Participants recruited from control barbershops will receive standard-of-care HIV prevention services which include facility-based HIV risk reduction counseling and testing and providing information about facility distributed HIV self-test kits.
|
Facility-based HIV risk reduction counseling
Facility-based HIV testing
Information about facility distributed HIV self-test kits
STI testing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To evaluate the feasibility and acceptability of a barbershop based HIV prevention initiative
Time Frame: Week 26 and Week 52
|
Consistent with this primary study objective, the following endpoint will be assessed from participants in the intervention group: Participant responses from surveys at Week 26 and Week 52 about acceptability of the intervention
|
Week 26 and Week 52
|
To evaluate the feasibility and acceptability of a barbershop based HIV prevention initiative
Time Frame: Week 13, Week 26, Week 39, Week 52, Week 65
|
Consistent with this primary study objective, the following endpoint will be assessed from participants in the intervention group: Barber responses from surveys about feasibility and acceptability of intervention
|
Week 13, Week 26, Week 39, Week 52, Week 65
|
To evaluate the feasibility and acceptability of a barbershop based HIV prevention initiative
Time Frame: Week 26 and Week 52
|
Consistent with this primary study objective, the following endpoint will be assessed from participants in the intervention group: Recruitment rates during enrollment and retention in study and barbershop activities at Week 26 and Week 52
|
Week 26 and Week 52
|
To evaluate the feasibility and acceptability of a barbershop based HIV prevention initiative
Time Frame: Week 13, Week 26, Week 39, Week 52, Week 65
|
Consistent with this primary study objective, the following endpoint will be assessed from participants in the intervention group: Frequency of barber-participant interactions
|
Week 13, Week 26, Week 39, Week 52, Week 65
|
To evaluate the feasibility and acceptability of a barbershop based HIV prevention initiative
Time Frame: Week 13, Week 26, Week 39, Week 52, Week 65
|
Consistent with this primary study objective, the following endpoint will be assessed from participants in the intervention group: Proportion of barber-participant interactions that include delivery of the intervention
|
Week 13, Week 26, Week 39, Week 52, Week 65
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To compare completion of self-initiated HIV testing between intervention and control groups
Time Frame: Week 26 and Week 52
|
Consistent with this secondary study objective, the following endpoint will be assessed: Self-report of HIV test conducted between enrollment and study visit at Week 26, and between the Week 26 and Week 52 study visits
|
Week 26 and Week 52
|
To evaluate the preliminary effectiveness of the intervention on change in risk behaviors associated with HIV acquisition
Time Frame: Week 26 and Week 52
|
Consistent with this secondary study objective, the following endpoint will be assessed: Self-reported risk behaviors at Week 26 and Week 52, including condom use
|
Week 26 and Week 52
|
To evaluate the preliminary effectiveness of the intervention on change in risk behaviors associated with HIV acquisition
Time Frame: Week 26 and Week 52
|
Consistent with this secondary study objective, the following endpoint will be assessed: Self-reported risk behaviors at Week 26 and Week 52, including number of total sexual partners
|
Week 26 and Week 52
|
To evaluate the preliminary effectiveness of the intervention on change in risk behaviors associated with HIV acquisition
Time Frame: Week 26 and Week 52
|
Consistent with this secondary study objective, the following endpoint will be assessed: Self-reported risk behaviors at Week 26 and Week 52, including number of new sexual partners
|
Week 26 and Week 52
|
To compare interest in or use of HIV prevention services between intervention and control groups
Time Frame: Week 26 and Week 52
|
Consistent with this secondary study objective, the following endpoint will be assessed: Voluntary medical male circumcision (VMMC) during the study
|
Week 26 and Week 52
|
To compare interest in or use of HIV prevention services between intervention and control groups
Time Frame: Week 26 and Week 52
|
Consistent with this secondary study objective, the following endpoint will be assessed: Self-reported referral to PEP care or use of PEP
|
Week 26 and Week 52
|
To compare interest in or use of HIV prevention services between intervention and control groups
Time Frame: Week 26 and Week 52
|
Consistent with this secondary study objective, the following endpoint will be assessed: Self-reported referral to PrEP care or use of any PrEP method during the study
|
Week 26 and Week 52
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Zubair Lukyamuzi, MBChB, MPH, Makerere University, Johns Hopkins University Collaboration (MU-JHU)
- Study Chair: Brenda Gati Mirembe, MBChB, MscEpi, Makerere University, Johns Hopkins University Collaboration (MU-JHU)
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Urogenital Diseases
- Genital Diseases
- HIV Infections
Other Study ID Numbers
- HPTN 111
- UM1AI068619-17 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...CompletedHIV PositiveIndonesia, Ukraine, Vietnam
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
-
Boston Children's HospitalNational Institute on Minority Health and Health Disparities (NIMHD)Completed
Clinical Trials on General, status-neutral HIV education
-
National Institute on Drug Dependence, ChinaMan Wellness Center, Beijing, ChinaNot yet recruitingSexually Transmitted Diseases | HIV/AIDS | Prevention
-
Ege UniversityRecruitingBody Image | Eating Behavior | Nutrition, Healthy | Eating Habit | Nutrition Disorders in AdolescenceTurkey
-
Hospices Civils de LyonNot yet recruiting
-
Fundacion para la Investigacion Biomedica del Hospital...Instituto de Salud Carlos IIICompletedHIV Infection | HCV CoinfectionSpain
-
Azienda Ospedaliera Universitaria Integrata VeronaCompleted
-
National Institute of Allergy and Infectious Diseases...Centers for Disease Control and PreventionCompleted
-
National Development and Research Institutes, Inc.St. Luke's-Roosevelt Hospital Center; Daytop (adolescent treament program)Unknown
-
VA Office of Research and DevelopmentRecruitingPhysical Deconditioning | MultimorbidityUnited States
-
AmgenCompleted
-
Eunice Kennedy Shriver National Institute of Child...National Institute of Nursing Research (NINR)Completed